In addition to Weibo, there is also WeChat
Please pay attention
WeChat public account
Shulou
2025-01-24 Update From: SLTechnology News&Howtos shulou NAV: SLTechnology News&Howtos > IT Information >
Share
Shulou(Shulou.com)11/24 Report--
February 19-Synchron, an American brain-computer interface startup that has been working on technologies designed to improve the daily lives of paralyzed patients, is testing brain-computer interface technology on seven patients in the United States and Australia, allowing them to use their brain minds to manipulate devices such as computer cursors and smart homes.
Tom Oxley, chief executive of Synchron, said in an interview: "I have seen several times when patients and their families find it hard to believe and are very happy when they are better able to take care of themselves. This technology helps them participate in communication in a more natural way."
Synchron was founded in 2012 to develop the emerging brain-computer interface (BCI) technology, a system that deciphers brain signals and converts them into external technical instructions. Perhaps the best-known company in this field is Neuralink, thanks to the high profile of its founder, Elon Musk, who is also the chief executive of Tesla, SpaceX and Twitter.
Musk hopes to evolve brain-computer interface technology from radical scientific experiments into a huge medical business, but he is not the only tech billionaire betting. In December, Synchron announced that it had raised $75 million, with investors including Microsoft co-founder Bill Gates and Amazon founder Jeff Bezos's investment company.
Synchron's technology is "more scalable" in August 2020, the US Food and Drug Administration (FDA) awarded Synchron's product the title of "groundbreaking device". This means that its products have the potential to become medical devices for better treatment of critically ill patients. The following year, Synchron became the first company to obtain a research equipment exemption from FDA to conduct permanent implant trials in human patients.
Synchron is recruiting patients for early feasibility trials to show that the technology can be safely used in humans. During the study, six American patients will be implanted with Synchron brain-computer interface devices. The company's chief business officer, Kurt Hagstrom (Kurt Haggstrom), said implants had been completed in three patients.
Synchron does not have any revenue yet, and a spokesman said the company would not comment on the final cost of the operation. Synchron said that while many competitors had to implant brain-computer interface devices through brain surgery, Synchron relied on a less invasive approach based on decades of intravascular technology.
Synchron's brain-computer interface device is implanted through blood vessels, which Oxley, its chief executive, calls the "natural highway" into the brain. Synchron's stent, called Stentrode, is equipped with a miniature sensor and is transported to a large vein next to the motor cortex. The Stentrode is connected to an antenna located under the skin of the patient's chest to collect raw brain data and send it from the inside of the body to external devices.
Peter Yoo, a neuroscience expert and company executive at Synchron, said that because the device is not plugged directly into the brain, the quality of the brain's signals is not perfect. But he says the brain doesn't like to be touched by foreign bodies, and the surgery is less invasive, so it's easier to perform. "about 2000 interventionists can perform this type of surgery, which is more scalable than brain surgery or drilling that only neurosurgeons can perform," Peter Yoo said. "
Restoring the ability to send text messages is critical for people with severe paralysis or degenerative diseases such as amyotrophic lateral sclerosis (ALS), Synchron's technology can help them regain the ability to communicate with friends, family and the outside world by typing, texting and accessing social media. Patients can use Synchron's brain-computer interface device to shop online and manage their health and finances, but Oxley says what excites them most is sending and receiving text messages.
Oxley added: "losing the ability to send text messages leaves people in extreme isolation, and restoring that ability is of great significance."
In December 2021, Oxley handed over his Twitter account to a patient named Philip O'Keefe, who suffers from amyotrophic lateral sclerosis and has difficulty moving his hands. About 20 months ago, O'Keefe was implanted with Synchron's brain-computer interface device. O'Keefe wrote on Oxley's page: "Hello, World! short tweets, great progress!"
Synchron's technology has attracted the attention of competitors. Mr Musk reportedly approached the company last year to discuss potential investment deals. Synchron declined to comment and Neuralink did not respond to a request for comment.
Neuralink is developing a brain-computer interface device that can be implanted directly into brain tissue, and although the company has not yet tested it on humans, Musk has said he hopes to start human testing this year.
Hagstrom, Synchron's chief commercial officer, said the financing received by the company would help accelerate product development and drive it to conduct key clinical trials to commercialize its products as soon as possible.
Alex Morgan, a partner at Khosla Ventures, says that while Synchron's device looks like science fiction, it is rooted in "real science" and has had a significant impact on patients' lives. He added: "so far, Synchron has actually been helping people. For me, this is really extraordinary."
In January, the medical journal American Medical Association Neurology (JAMA Neuroology) published the long-term safety results of a peer-reviewed brain-computer interface trial conducted by Synchron in four Australian patients. The study found that the technology was so safe that there was no significant change in signal quality or performance over a period of 12 months. "this is a very critical recognition for us," Hagstrom said. "
Hagstrom also said that in the brain-computer interface industry, commercialization is the focus of all participants. "I always like to compete, so it's very important for me to enter the market first," he said. we will meet patients and discuss their needs and other things, so when you see this, you will talk to these families and their caregivers, and you want to help them in their daily life as quickly as possible. "
Welcome to subscribe "Shulou Technology Information " to get latest news, interesting things and hot topics in the IT industry, and controls the hottest and latest Internet news, technology news and IT industry trends.
Views: 236
*The comments in the above article only represent the author's personal views and do not represent the views and positions of this website. If you have more insights, please feel free to contribute and share.
Continue with the installation of the previous hadoop.First, install zookooper1. Decompress zookoope
"Every 5-10 years, there's a rare product, a really special, very unusual product that's the most un
© 2024 shulou.com SLNews company. All rights reserved.